Heimdall Insights

Global Autism Spectrum Disorder Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: July 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Autism Spectrum Disorder Therapeutics Market was valued at $2.4 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.8% CAGR, to an estimated market size of $3.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Global Autism Spectrum Disorder (ASD) Therapeutics Market encompasses pharmacological agents (such as antipsychotics, stimulants, and SSRIs), behavioral interventions, and diagnostic services designed to manage core and associated symptoms of ASD. The scope includes treatments integrated into healthcare and educational systems but excludes non-clinical social support services and general educational tools.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Autism Spectrum Disorder Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Antipsychotics
  • Stimulants
  • SSRIs & Antidepressants
  • Novel & Other Therapies